Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inflammation and type 2 diabetes: from basic science to treatment.

Literature DB >> 31240442

Inflammation and type 2 diabetes: from basic science to treatment.

Marc Y Donath¹.

Abstract

Entities: Disease

Year: 2019 PMID： 31240442 DOI： 10.1007/s00281-019-00749-0

Source DB: PubMed Journal: Semin Immunopathol ISSN： 1863-2297 Impact factor: 9.623

× No keyword cloud information.

17 in total

Review 1. Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?

Authors: Milica Popovic; Gideon Sartorius; Mirjam Christ-Crain
Journal: Semin Immunopathol Date: 2019-05-28 Impact factor: 9.623

Review 2. The role of inflammation in diabetic eye disease.

Authors: Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal: Semin Immunopathol Date: 2019-06-07 Impact factor: 9.623

Review 3. Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors: Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal: Semin Immunopathol Date: 2019-04-25 Impact factor: 9.623

Review 4. Transcriptional control of macrophage polarisation in type 2 diabetes.

Authors: Karima Drareni; Jean-François Gautier; Nicolas Venteclef; Fawaz Alzaid
Journal: Semin Immunopathol Date: 2019-05-02 Impact factor: 9.623

Review 5. Targeting inflammation in the treatment of type 2 diabetes: time to start.

Authors: Marc Y Donath
Journal: Nat Rev Drug Discov Date: 2014-05-23 Impact factor: 84.694

6. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors: Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal: N Engl J Med Date: 2017-08-27 Impact factor: 91.245

7. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure.

Authors: Brendan M Everett; Jan H Cornel; Mitja Lainscak; Stefan D Anker; Antonio Abbate; Tom Thuren; Peter Libby; Robert J Glynn; Paul M Ridker
Journal: Circulation Date: 2019-03-05 Impact factor: 29.690

Review 8. Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes.

Authors: Christian Herder; Norbert Hermanns
Journal: Semin Immunopathol Date: 2019-02-18 Impact factor: 9.623

Review 9. Islet inflammation in type 2 diabetes.

Authors: Marianne Böni-Schnetzler; Daniel T Meier
Journal: Semin Immunopathol Date: 2019-04-15 Impact factor: 9.623

10. Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes.

Authors: Joanne Sloan-Lancaster; Eyas Abu-Raddad; John Polzer; Jeffrey W Miller; Joel C Scherer; Andrea De Gaetano; Jolene K Berg; William H Landschulz
Journal: Diabetes Care Date: 2013-03-20 Impact factor: 19.112

1 in total

1. The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.

Authors: Petra I Lorenzo; Eugenia Martin Vazquez; Livia López-Noriega; Esther Fuente-Martín; José M Mellado-Gil; Jaime M Franco; Nadia Cobo-Vuilleumier; José A Guerrero Martínez; Silvana Y Romero-Zerbo; Jesús A Perez-Cabello; Sabrina Rivero Canalejo; Antonio Campos-Caro; Christian Claude Lachaud; Alejandra Crespo Barreda; Manuel Aguilar-Diosdado; Eduardo García Fuentes; Alejandro Martin-Montalvo; Manuel Álvarez Dolado; Franz Martin; Gemma Rojo-Martinez; David Pozo; Francisco J Bérmudez-Silva; Valentine Comaills; José C Reyes; Benoit R Gauthier
Journal: Theranostics Date: 2021-05-12 Impact factor: 11.556

1 in total